KZA 0.00% 8.0¢ kazia therapeutics limited

Interview with Dr Matt Dun on DIPG research and GDC-0084, page-30

  1. 193 Posts.
    lightbulb Created with Sketch. 85
    I‘m a little confused by some of the above comments regarding a particular trial too. The drug is obviously moving to a phase 3 trial. However, they seem to be taking particular exception with a phase 2 trial which also would have been part of the reason the FDA granted Fast Track Designation for this indication.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.